Sarcomas

Latest News

NBTXR3 Plus Radiotherapy Does Not Negatively Affect Quality of Life in Soft Tissue Sarcoma
NBTXR3 Plus Radiotherapy Does Not Negatively Affect Quality of Life in Soft Tissue Sarcoma

December 1st 2021

An expert from the Institut Curie discusses the risk-benefit ratio associated with NBTXR3 plus radiotherapy for the treatment of patients with soft tissue sarcoma.

PROMIS Scores Show Patients with Wound Complications Following Radiation Therapy Report Higher Anxiety, Physical Dysfunction
PROMIS Scores Show Patients with Wound Complications Following Radiation Therapy Report Higher Anxiety, Physical Dysfunction

October 18th 2021

Next-Generation Sequencing Unearths Actionable Mutations in Sarcoma
Next-Generation Sequencing Unearths Actionable Mutations in Sarcoma

February 21st 2021

FDA Grants Devimistat Orphan Drug Status for Soft Tissue Sarcoma
FDA Grants Devimistat Orphan Drug Status for Soft Tissue Sarcoma

November 26th 2020

Better Diagnosing Is Needed in Sarcoma
Better Diagnosing Is Needed in Sarcoma

November 21st 2020

More News

© 2023 MJH Life Sciences

All rights reserved.